Since this medicine is administered in a healthcare setup the chances of missed dose are less. The missed dose of this medicine should be administered as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose. Do not double the dose to make up for the missed dose.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Tramadol (severe)
Zidovudine (severe)
Bexarotene (severe)
Clozapine (severe)
Deferiprone (severe)
This medicine is used to treat hairy cell leukemia which is a rare, slow-growing cancer of the bone marrow and produces too many white blood cells (B lymphocytes). These excess B cells are abnormal and look "hairy" under a microscope.
This medicine is used in the treatment of Kaposi's Sarcoma which is a type of tumor that develops from the cells that line lymph or blood vessels secondary to AIDS.
This medicine is used in the treatment of Multiple Myeloma which is a type of blood cancer which affects white blood cells.
This medicine is used in the treatment of Malignant Melanoma which is a type of skin cancer.
This medicine is used in the treatment of is a type of cancer of the blood and bone marrow which affects all the white blood cells except lymphocytes.
This medicine is used to treat chronic hepatitis C which is a liver disease caused by hepatitis C virus (HCV).
This medicine is used to treat chronic hepatitis B which is a liver disease caused by hepatitis B virus (HBV).
This medicine is used in the treatment of Non-Hodgkin's Lymphoma which is a cancer of the lymphatic system which affects a type of white blood cells called lymphocytes.
This medicine is used in the treatment of Genital warts which is a sexually transmitted skin disease caused by the Human Papilloma Virus (HPV).
Depression
Difficulty in breathing
Swelling or puffiness of face
Thyroid imbalances
Decrease in blood cell ount
Loss of appetite
Headache
Dizziness
Dry mouth
Blurred vision
Nausea and vomiting
Weight loss
This medicine is not recommended for use in patients with a known allergy to 2A INFRON ALPHA 3MIU Injection 1s or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with autoimmune hepatitis due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with decompensated liver disease due to the increased risk of worsening of the patient's condition.